172 related articles for article (PubMed ID: 23889949)
1. Novel pharmacologic treatment attenuates septic shock and improves long-term survival.
Zhao T; Li Y; Liu B; Liu Z; Chong W; Duan X; Deperalta DK; Velmahos GC; Alam HB
Surgery; 2013 Aug; 154(2):206-13. PubMed ID: 23889949
[TBL] [Abstract][Full Text] [Related]
2. Surviving lethal septic shock without fluid resuscitation in a rodent model.
Li Y; Liu B; Fukudome EY; Kochanek AR; Finkelstein RA; Chong W; Jin G; Lu J; deMoya MA; Velmahos GC; Alam HB
Surgery; 2010 Aug; 148(2):246-54. PubMed ID: 20561658
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of suberoylanilide hydroxamic acid against LPS-induced septic shock in rodents.
Li Y; Liu B; Zhao H; Sailhamer EA; Fukudome EY; Zhang X; Kheirbek T; Finkelstein RA; Velmahos GC; deMoya M; Hales CA; Alam HB
Shock; 2009 Nov; 32(5):517-23. PubMed ID: 19295477
[TBL] [Abstract][Full Text] [Related]
4. Treatment with histone deacetylase inhibitor attenuates MAP kinase mediated liver injury in a lethal model of septic shock.
Finkelstein RA; Li Y; Liu B; Shuja F; Fukudome E; Velmahos GC; deMoya M; Alam HB
J Surg Res; 2010 Sep; 163(1):146-54. PubMed ID: 20599223
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates Toll-like receptor 4 signaling in lipopolysaccharide-stimulated mouse macrophages.
Chong W; Li Y; Liu B; Zhao T; Fukudome EY; Liu Z; Smith WM; Velmahos GC; deMoya MA; Alam HB
J Surg Res; 2012 Dec; 178(2):851-9. PubMed ID: 22868051
[TBL] [Abstract][Full Text] [Related]
6. Citrullinated histone H3: a novel target for the treatment of sepsis.
Li Y; Liu Z; Liu B; Zhao T; Chong W; Wang Y; Alam HB
Surgery; 2014 Aug; 156(2):229-34. PubMed ID: 24957671
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of histone deacetylase 6 improves long-term survival in a lethal septic model.
Li Y; Zhao T; Liu B; Halaweish I; Mazitschek R; Duan X; Alam HB
J Trauma Acute Care Surg; 2015 Feb; 78(2):378-85. PubMed ID: 25757125
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of suberoylanilide hydroxamic acid against lipopolysaccharide-induced liver damage in rodents.
Zhao Y; Zhou P; Liu B; Bambakidis T; Mazitschek R; Alam HB; Li Y
J Surg Res; 2015 Apr; 194(2):544-550. PubMed ID: 25479907
[TBL] [Abstract][Full Text] [Related]
9. Selective Inhibition of SIRT2 Improves Outcomes in a Lethal Septic Model.
Zhao T; Alam HB; Liu B; Bronson RT; Nikolian VC; Wu E; Chong W; Li Y
Curr Mol Med; 2015; 15(7):634-41. PubMed ID: 26299770
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor treatment attenuates coagulation imbalance in a lethal murine model of sepsis.
Zhao T; Li Y; Liu B; Wu E; Sillesen M; Velmahos GC; Halaweish I; Alam HB
Surgery; 2014 Aug; 156(2):214-20. PubMed ID: 24957668
[TBL] [Abstract][Full Text] [Related]
11. Identification of citrullinated histone H3 as a potential serum protein biomarker in a lethal model of lipopolysaccharide-induced shock.
Li Y; Liu B; Fukudome EY; Lu J; Chong W; Jin G; Liu Z; Velmahos GC; Demoya M; King DR; Alam HB
Surgery; 2011 Sep; 150(3):442-51. PubMed ID: 21878229
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase III as a potential therapeutic target for the treatment of lethal sepsis.
Zhao T; Li Y; Liu B; Bronson RT; Halaweish I; Alam HB
J Trauma Acute Care Surg; 2014 Dec; 77(6):913-9; discussion 919. PubMed ID: 25051385
[TBL] [Abstract][Full Text] [Related]
13. Creating a prosurvival phenotype through a histone deacetylase inhibitor in a lethal two-hit model.
Liu Z; Li Y; Chong W; Deperalta DK; Duan X; Liu B; Halaweish I; Zhou P; Alam HB
Shock; 2014 Feb; 41(2):104-8. PubMed ID: 24430491
[TBL] [Abstract][Full Text] [Related]
14. Creating a "pro-survival" phenotype through epigenetic modulation.
Li Y; Liu B; Gu X; Kochanek AR; Fukudome EY; Liu Z; Zhao T; Chong W; Zhao Y; Zhang D; Libermann TA; Alam HB
Surgery; 2012 Sep; 152(3):455-64. PubMed ID: 22938904
[TBL] [Abstract][Full Text] [Related]
15. Selective histone deacetylase-6 inhibition attenuates stress responses and prevents immune organ atrophy in a lethal septic model.
Zhao T; Li Y; Bronson RT; Liu B; Velmahos GC; Alam HB
Surgery; 2014 Aug; 156(2):235-42. PubMed ID: 24947640
[TBL] [Abstract][Full Text] [Related]
16. Selective histone deacetylase 6 inhibition prolongs survival in a lethal two-hit model.
Cheng X; Liu Z; Liu B; Zhao T; Li Y; Alam HB
J Surg Res; 2015 Jul; 197(1):39-44. PubMed ID: 25837686
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of histone deacetylase 6 alters the composition of circulating blood cells in a lethal septic model.
Zhao T; Li Y; Liu B; Halaweish I; Mazitschek R; Alam HB
J Surg Res; 2014 Aug; 190(2):647-54. PubMed ID: 24613069
[TBL] [Abstract][Full Text] [Related]
18. The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines.
Leoni F; Zaliani A; Bertolini G; Porro G; Pagani P; Pozzi P; Donà G; Fossati G; Sozzani S; Azam T; Bufler P; Fantuzzi G; Goncharov I; Kim SH; Pomerantz BJ; Reznikov LL; Siegmund B; Dinarello CA; Mascagni P
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2995-3000. PubMed ID: 11867742
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory properties of histone deacetylase inhibitors: a mechanistic study.
Chong W; Li Y; Liu B; Liu Z; Zhao T; Wonsey DR; Chen C; Velmahos GC; deMoya MA; King DR; Kung AL; Alam HB
J Trauma Acute Care Surg; 2012 Feb; 72(2):347-53; discussion 353-4. PubMed ID: 22327976
[TBL] [Abstract][Full Text] [Related]
20. Protective Effect of Tubastatin A in CLP-Induced Lethal Sepsis.
Deng Q; Zhao T; Pan B; Dennahy IS; Duan X; Williams AM; Liu B; Lin N; Bhatti UF; Chen E; Alam HB; Li Y
Inflammation; 2018 Dec; 41(6):2101-2109. PubMed ID: 30047002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
